Supernus Pharmaceuticals (SUPN) Earnings (2011 - 2026)
Supernus Pharmaceuticals (SUPN) earnings from Mar 31, 2011 to Mar 31, 2026. The TTM Supernus Pharmaceuticals (SUPN) earnings is -$29M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Annual Earnings change of Supernus Pharmaceuticals (SUPN)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$2.29M | -94.06% |
| 2025 | -$39M | -152.19% |
| 2024 | $74M | +5495.45% |
| 2023 | $1.32M | -97.83% |
| 2022 | $61M | +13.65% |
| 2021 | $53M | -57.92% |
| 2020 | $127M | +12.29% |
| 2019 | $113M | +1.87% |
| 2018 | $111M | +93.77% |
| 2017 | $57M | -37.21% |
| 2016 | $91M | +554.38% |
| 2015 | $14M | -227.66% |
| 2014 | -$11M | -51.27% |
| 2013 | -$22M | -51.58% |
| 2012 | -$46M | -185.99% |
| 2011 | $54M | -239.94% |
| 2010 | -$38M | N/A |